Intrinsiqq
Silexion Therapeutics Corp. logo

Silexion Therapeutics Corp. Insider Trading

SLXN

Compare
Last 12 months

Insiders sold 31K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. CSO and CDO Mitchell Shirvan sold 31K on Mar 26, 45% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.

Net open-market
−31K
0 buys · 1 sale
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 1
executives and directors
Last open-market buy
None
in the last two years

Get an email when SLXN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Mar 26No plan
    Mitchell Shirvan
    CSO and CDO · sold 22,818 at $1.36
    31K
    45% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SLXN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with SLXN

CompareIntrinsic value
STROSutro Biopharma, Inc.
$8.60-1.38%10
AIMAIM ImmunoTech Inc.
$0.11-4.50%25
ARMPArmata Pharmaceuticals Inc.
$3.03+1.68%30
CRDFCardiff Oncology Inc.
$0.85-4.18%36
LCTXLineage Cell Therapeutics Inc.
$0.77-5.87%10
FDMT4D Molecular Therapeutics, Inc.
$10.23-4.57%40
PROKProKidney Corp
$1.04-1.89%10
FENCFennec Pharmaceuticals Inc.
$13.10-2.60%50

Spot a number that looks wrong? Check it in SLXN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing SLXN

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.